Background: Allergic contact dermatitis is considered one of the most common causes of eyelid dermatitis. In addition to metals and topical antibiotics, fragrances have emerged as a leading source of contact allergy for individuals with this condition.
A LLERGIC CONTACT dermatitis (ACD) is considered the most common cause of eyelid dermatitis. 1Y5 Important sources of eyelid contact allergy include metals, cosmetics, fragrances, topical medications, and cleaning products. In addition, the thin skin of the eyelids is susceptible to airborne allergens such as pollen, dust mites, animal dander, and volatile chemicals. 6 Allergens may also be transferred to the eyelids from other primary contact sites such as the hands, leading to ''ectopic'' ACD. Previous studies have found that 79% to 90% of patients presenting with eyelid dermatitis are female, which may reflect the increased use of cosmetic products in this population. 1 Irritant contact dermatitis, atopic dermatitis, sebhorrheic dermatitis, and psoriasis serve as other common causes of dermatitis involving the eyelids. 6 Fragrances have emerged as a frequent source of ACD, affecting approximately 1% of the general population and 6% to 14% of patients with contact dermatitis. 7 Results from the North American Contact Dermatitis Group (NACDG) found that myroxylon pereirae and fragrance mix I (FM I) were the second and third most common allergens detected on patch testing during the 2-year period between 2005 and 2006. 8 Numerous studies have demonstrated that fragrances may be a particularly significant cause of eyelid ACD. 1, 2, 9 For example, in their retrospective analysis of 105 patients presenting with eyelid dermatitis, Amin et al 1 found that 43.8% were diagnosed with ACD, with fragrances resulting in the greatest number of relevant reactions (28.3%). In this same study, positive relevant patch tests to fragrance mix and other fragrances also occurred significantly more often in those presenting with eyelid dermatitis compared with a group of patients without eyelid involvement (28.3% vs 15.3%, P = 0.0423). 1 Similarly, in a group of 150 patients with eyelid dermatitis with or without other areas of involvement, patch test reactions to fragrance mix occurred more frequently than in a separate cohort of patients without eyelid dermatitis. 2 Given the importance of fragrances in eyelid dermatitis, we attempted to determine the added benefit of fragrance series testing in this population. All patients presenting to our clinic with eyelid dermatitis during a 4.5-year period were tested with both North American standard and fragrance trays. This also allowed us to investigate the value of standard tray fragrance markers in eyelid dermatitis.
MATERIALS AND METHODS
All patients with eyelid dermatitis, with or without involvement of other parts of the body, seen at our facility between May 2006 and October 2010 were patch tested with the North American standard and fragrance series. Patients were also tested with any other relevant trays or personal products. Most patients were referred by other providers for a suspected diagnosis of ACD. Patch testing was performed with allergens from Chemotechnique Diagnostics (Malmö, Sweden) using Finn Chambers applied to the back with Scanpor adhesive. Readings were done at 48 and 96 hours and were scored according to standard NACDG method. 10 Only positive patch test results of present relevance (ie, definite, probable, or possible) were included for analysis, and positive allergens of past or unknown relevance were excluded. 8 The percentage of patients with 1 or more positive reactions to allergens within the fragrance series was determined. For each of these individuals, we determined whether the information obtained from fragrance testing led to the detection of additional fragrance allergens that would not have been detected by the standard tray alone. These cases included patients with negative reactions to fragrance markers within the standard series (ie, FM I, FM II, myroxylon pereirae, and cinnamic aldehyde) but with positive reactions to 1 or more components of those markers (specifically FM I and/or FM II) on the fragrance tray. It also included patients with positive reactions to allergens unique to the fragrance series. Those with both positive fragrance markers on the standard tray and positive reactions on the fragrance tray to the components of those markers were not considered to have benefited from fragrance series testing for the purposes of this study. Given the complex composition and variety of potential allergens within myroxylon pereirae, we did not consider missed myroxylon pereirae reactions. For example, allergens such as benzyl salicylate, benzyl alcohol, and vanillin were classified as unique to the fragrance series and not as a constituent of myroxylon pereirae.
Fragrance mix I consists of 8 components with 1% sorbitan sesquioleate as an emulsifying agent: isoeugenol (1%), eugenol (1%), cinnamic aldehyde (1%), cinnamic alcohol (1%), hydroxycitronellal (1%), geraniol (1%), >-amylcinnamaldehyde (1%), and oakmoss absolute (1%). Each separate FM I ingredient on the fragrance tray was tested at 2% (with the exception of cinnamic aldehyde at 1%) without sorbitan sesquioleate. Cinnamic aldehyde was also included separately on the standard tray at a concentration of 1% in petrolatum. Fragrance mix II has 6 components without sorbitan sesquioleate: citral (1%), hydroxyisohexyl 3-cyclohexene carboxaldehyde (2.5%), farnesol (2.5%), citronellol (0.5%), >-hexyl cinnamic aldehyde (5%), and coumarin (2.5%). 11 These FM II ingredients were tested at the same concentrations within the fragrance series. Although FM II was a part of the fragrance series used in this study, we chose to include it within the standard series in our analysis because most standard trays have now incorporated it as a screening fragrance allergen.
RESULTS

Frequency of Positive Patch Test Reactions
A total of 100 patients with eyelid dermatitis were patch tested during the 4.5-year period between May 2006 and October 2010. The patch test population consisted of 96 females and 4 males, with a mean age of 47 years. Eighty-eight patients (88%) tested positive to at least 1 relevant allergen on the standard and/or fragrance trays. Table 1 lists the number of patients who had positive reactions to specific relevant allergens. Fragrance mix II (19 patients), FM I (17 patients), and myroxylon pereirae (17 patients) were the most common allergens eliciting a positive response, followed by nickel sulfate (15 patients), cinnamic alcohol (15 patients), cinnamic aldehyde (11 patients), neomycin sulfate (11 patients), gold sodium thiosulfate (8 patients), and colophony (7 patients). No patient had a positive reaction to sorbitan sesquioleate, which was included on the standard tray to monitor for potential false-positive FM I responses.
Benefit of Fragrance Series Testing
Of 100 individuals, 42 (42%) tested positive to 1 or more allergens on the fragrance tray. Of these patients, 15 (36%) had no fragrance markers detected on the standard series, and these allergens would therefore have been missed had fragrance series testing not been performed. Five of these cases reacted to 1 or more components of FM I or FM II, and another 5 cases reacted to other allergens in the fragrance series. The remaining 5 tested positive to components of FM I or FM II and other allergens on the fragrance tray ( Fig. 1 ).
In addition, of those who had positive reactions to at least 1 fragrance marker on the standard tray (41 patients), fragrance tray inclusion resulted in the detection of additional allergens in 16 patients. Similar to the 15 patients described above, this group included individuals with negative reactions to 1 or more fragrance markers on the standard tray but that tested positive to 1 or more components of those markers in the fragrance series, as well as patients who had positive reactions to allergens unique to the fragrance series ( Fig. 1) .
A total of 19 cases had 1 or more positive allergens that were unique to the fragrance series and not directly screened for by the standard series (ie, these allergens were not a component of FM I or FM II and did not include cinnamic aldehyde). The most common allergens in this subgroup were ylang-ylang oil (6 patients) and sandalwood oil (4 patients), followed by musk xylene, musk ketone, lavender absolute, vanillin, and jasmine absolute (each with 2 patients). Narcissus absolute, benzyl alcohol, jasmine synthetic, and methyl anthranilate each accounted for 1 positive patch test reaction. Ten of these 19 patients tested negative for all fragrance markers on the standard tray, and 4 of 19 reacted to more than 1 unique fragrance tray allergen.
Of 100 patients, 14 (14%) had a positive fragrance marker on the standard tray but no reaction to any allergens on the fragrance tray. When combined with the 42 individuals with at least 1 positive fragrance tray reaction, a total of 56 patients tested positive for 1 or more fragrances either on the standard or fragrance series (Fig. 2) .
FM I and FM II as Fragrance Markers
As seen in Table 1 , 19 patients were positive to FM II and 17 patients were positive to FM I within the standard series. Of those with positive reactions to FM II, 7 (37%) tested positive to at least 1 component of the mix within the fragrance series. In contrast, 10 (59%) of the patients who reacted to FM I had a corresponding positive reaction to 1 or more of its components on the fragrance tray.
When considering the reverse situation, of the 25 patients who tested positive to a component of FM I, 11 (44.0%) also had a positive reaction to FM I. Of the 13 individuals who reacted to a constituent of FM II on the fragrance tray, 7 (53.9%) also tested positive to FM II. A total of 20 cases tested negative for either FM I and/or FM II but tested positive to a corresponding component of the mix on the fragrance tray (eg, if a patient tested negative for FM I in the standard series but positive for cinnamic alcohol in the fragrance series). Fragrance mix I was the most commonly ''missed'' allergen, accounting for 14 of 20 patients, followed by FM II with 6 of 20 patients. Figure 3 shows the contribution of each fragrance marker in screening for fragrance allergy, as well as the number of patients with more than 1 positive marker.
DISCUSSION
In this study, fragrances were the most common allergens eliciting positive patch test results in those presenting with eyelid dermatitis, with FM II, FM I, and myroxylon pereirae making up the top 3 allergens (Table 1 ). These results are consistent with other investigations, which have established fragrances as a leading cause of eyelid dermatitis. 1, 2, 9 In addition to the studies discussed above, the NACDG has published data on the most frequently encountered relevant allergens in patients presenting with dermatitis of the eyelids only during the 2003 to 2004 study period. 12 They found that gold was the most common offending allergen accounting for 8.2% of cases, followed by FM I (7.1%), myroxylon pereirae (6.3%), nickel sulfate (6.0%), and neomycin (3.3%). 12 Amin et al reported similar results with FM I and other fragrances (28.3%), nickel sulfate (13%), neomycin and other aminoglycosides (10.9%), oleamidopropyl dimethylamine (10.9%), and benzalkonium chloride (8.7%) constituting the top 5 relevant allergens in those with eyelid dermatitis. 1 Although the exact percentages have varied, reports have consistently shown fragrances, metals, and topical antibiotics to be important sources of eyelid ACD.
Our results demonstrate the potential benefit of fragrance tray testing in the initial evaluation of eyelid dermatitis, given that 15% (15/100 patients) of the study population tested negative for all fragrance markers on the standard series, but positive for specific allergens within the fragrance series. In addition, another 16 patients with 1 or more positive standard tray fragrance markers benefited from fragrance tray testing through the detection of additional fragrance allergens that were either unique to the fragrance tray or missed by the standard tray. Other studies have supported the use of fragrance series testing in cases where there is high clinical suspicion of fragrance allergy. For example, Katsarma and Gawkrodger 13 conducted a study that evaluated the efficacy of FM I as a screen for fragrance allergy in those with suspected fragrance contact dermatitis. They found that 6.6% of patients (6/91) with positive allergic reactions to fragrances would have been missed had extended fragrance series testing not been performed. Cuesta et al 7 recently reported that 9.3% of individuals (3/32) with suspected fragrance allergy exhibited fragrance series positivity despite testing negative for fragrance markers in the standard series. The authors also noted that fragrance series testing was of additional benefit in identifying specific contact allergens, given that 75% of those positive to FM I were also positive to allergens within the fragrance series. 7 Interestingly, a significant proportion of individuals who benefited from fragrance series testing tested negative for FM I and/or FM II but had positive reactions to their corresponding constituents on the fragrance tray. Discrepancies with fragrance mix testing have been described previously, with the more commonly reported scenario involving a positive patch test to the mix with a negative response to its components. For FM I, it is estimated that only 40% to 60% of individuals with positive reactions to the mix will test positive to 1 or more FM I constituents. 14Y16 Similarly, only 48% of patients who react to FM II test positive to at least one of its ingredients. 17 A possible explanation for this dissociation is that the FM I response may represent a false-positive reaction, either due to irritation or through the formation of a new allergen from 2 or more ingredients within the mix. 14 Alternatively, the absence of a reaction to separate FM I ingredients may signify a false-negative reaction resulting from constituent concentrations that are too low. 14 Although the separate ingredient concentrations used by many investigators are often the same as in the mix (1% in petrolatum), FM I also contains sorbitan sesquioleate as an emulsifier, which has been shown to enhance the absorption of its components. 18, 19 Furthermore, Johansen et al 20 have shown that allergens tested in combination may have synergistic effects on the elicitation response in those already sensitized to both substances.
The high occurrence of the reverse phenomenon in our study (testing negative to the mix but positive to its ingredients) may be attributed to the fact that the FM I allergens on the fragrance tray were each tested at 2% in petrolatum (except for cinnamic aldehyde at 1%), which likely increased their sensitivity relative to the 1% concentrations within the mix. Indeed, De Groot et al 21 reported negative FM I reactions that were associated with positive patch test reactions to its separate ingredients when tested at higher concentrations, suggesting that fragrance-sensitive patients may be missed because of false-negative FM I responses. However, in our study, only 59% of those reacting to FM I exhibited a positive reaction to 1 or more of its components. Although this percentage is similar to the 40% to 60% observed in other studies, one might expect a higher value with the higher concentration, potentially more sensitive ingredients that were used. In addition, FM II also seemed to have a high false-negative rate, with only 7 (54%) of 13 patients testing positive to the mix in addition to its constituents. This occurred despite the use of identical testing concentrations for the mix ingredients on the fragrance tray and within FM II. Furthermore, these observations differ from Frosch et al, 17 who found that individuals rarely have positive reactions to an individual component of the mix without also testing positive to the mix itself. At this time, we have no clear explanation for these discrepancies. However, even if we exclude those patients who only reacted to 1 or more ingredients of FM I or FM II despite testing negative to the mix (5 individuals, see left side of Figure 1 ), fragrance series testing would have still resulted in the detection of 10 additional cases (10% of the study population) of fragrance allergy that would have been missed by standard tray testing alone.
Although fragrances are a well-known cause of ACD of the eyelids, to our knowledge, no other studies have specifically evaluated the benefit of fragrance series testing in those presenting with eyelid dermatitis. With only 73.2% of fragrance allergy cases detected by fragrance markers within the North American standard series, our results suggest that there may be a significant benefit to fragrance series testing in this population. In addition, 42% of the study group tested positive to 1 or more fragrance tray allergens, allowing for further characterization of specific offending allergens and identification of individuals who would have been missed had fragrance series testing not been performed.
